Belinda Borrelli1. 1. Centers for Behavioral and Preventive Medicine, The Miriam Hospital; & Warren Alpert School of Medicine at Brown University, Providence, RI. USA.
Abstract
OBJECTIVES: To discuss methods of preservation of treatment fidelity in health behavior change trials conducted in public health contexts. METHODS: The treatment fidelity framework provided by the NIH's Behavioral Change Consortium (BCC) (1) includes five domains of treatment fidelity (Study Design, Training, Delivery, Receipt, and Enactment). A measure of treatment fidelity was previously developed and validated using these categories. RESULTS: Strategies for assessment, monitoring, and enhancing treatment fidelity within each of the five treatment fidelity domains are discussed. The previously created measure of treatment fidelity is updated to include additional items on selecting providers, additional confounders, theory testing, and multicultural considerations. CONCLUSIONS: Implementation of a treatment fidelity plan may require extra staff time and costs. However, the economic and scientific costs of lack of attention to treatment fidelity are far greater than the costs of treatment fidelity implementation. Maintaining high levels of treatment fidelity with flexible adaptation according to setting, provider, and patient is the goal for public health trials.
OBJECTIVES: To discuss methods of preservation of treatment fidelity in health behavior change trials conducted in public health contexts. METHODS: The treatment fidelity framework provided by the NIH's Behavioral Change Consortium (BCC) (1) includes five domains of treatment fidelity (Study Design, Training, Delivery, Receipt, and Enactment). A measure of treatment fidelity was previously developed and validated using these categories. RESULTS: Strategies for assessment, monitoring, and enhancing treatment fidelity within each of the five treatment fidelity domains are discussed. The previously created measure of treatment fidelity is updated to include additional items on selecting providers, additional confounders, theory testing, and multicultural considerations. CONCLUSIONS: Implementation of a treatment fidelity plan may require extra staff time and costs. However, the economic and scientific costs of lack of attention to treatment fidelity are far greater than the costs of treatment fidelity implementation. Maintaining high levels of treatment fidelity with flexible adaptation according to setting, provider, and patient is the goal for public health trials.
Authors: Barbara Resnick; Albert J Bellg; Belinda Borrelli; Carol Defrancesco; Rosemary Breger; Jacki Hecht; Daryl L Sharp; Chantal Levesque; Denise Orwig; Denise Ernst; Gbenga Ogedegbe; Susan Czajkowski Journal: Ann Behav Med Date: 2005-04
Authors: John S Baer; Samuel A Ball; Barbara K Campbell; Gloria M Miele; Eugene P Schoener; Kathlene Tracy Journal: Drug Alcohol Depend Date: 2006-10-04 Impact factor: 4.492
Authors: Valerie Spillane; Mary C Byrne; Molly Byrne; Claire S Leathem; Mary O'Malley; Margaret E Cupples Journal: J Adv Nurs Date: 2007-11 Impact factor: 3.187
Authors: Marilyn Johnson-Kozlow; Melbourne F Hovell; Liza S Rovniak; Laura Sirikulvadhana; Dennis R Wahlgren; Joy M Zakarian Journal: Nicotine Tob Res Date: 2008-12 Impact factor: 4.244
Authors: Geri R Donenberg; Mardge H Cohen; Charles Ingabire; Mary Fabri; Erin Emerson; Ashley D Kendall; Eric Remera; Olivier Manzi; Sabin Nsanzimana Journal: J Acquir Immune Defic Syndr Date: 2019-12 Impact factor: 3.731
Authors: Lauren Luther; Sadaaki Fukui; Jennifer M Garabrant; Angela L Rollins; Gary Morse; Nancy Henry; Dawn Shimp; Timothy Gearhart; Michelle P Salyers Journal: J Behav Health Serv Res Date: 2019-01 Impact factor: 1.505
Authors: Richard A Winett; Brenda M Davy; Jyoti Savla; Elaina L Marinik; Sarah A Kelleher; Sheila G Winett; Tanya M Halliday; David M Williams Journal: Transl Behav Med Date: 2015-06 Impact factor: 3.046
Authors: Jessica D Richardson; Sarah Grace Hudspeth Dalton; Jennifer Shafer; Janet Patterson Journal: Am J Speech Lang Pathol Date: 2016-12-01 Impact factor: 2.408
Authors: Joseph Guydish; Barbara K Campbell; Jennifer K Manuel; Kevin L Delucchi; Thao Le; K Michelle Peavy; Dennis McCarty Journal: Drug Alcohol Depend Date: 2013-11-04 Impact factor: 4.492